196 related articles for article (PubMed ID: 15591246)
41. 3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists.
Greenwood JR; Mewett KN; Allan RD; Martín BO; Pickering DS
Neuropharmacology; 2006 Jul; 51(1):52-9. PubMed ID: 16631211
[TBL] [Abstract][Full Text] [Related]
42. Picosecond dynamics of the glutamate receptor in response to agonist-induced vibrational excitation.
Kubo M; Shiomitsu E; Odai K; Sugimoto T; Suzuki H; Ito E
Proteins; 2004 Feb; 54(2):231-6. PubMed ID: 14696185
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate.
Jin R; Horning M; Mayer ML; Gouaux E
Biochemistry; 2002 Dec; 41(52):15635-43. PubMed ID: 12501192
[TBL] [Abstract][Full Text] [Related]
44. Low-mode docking search in iGluR homology models implicates three residues in the control of ligand selectivity.
Rodriguez J; Carcache L; Rein KS
J Mol Recognit; 2005; 18(2):183-9. PubMed ID: 15476293
[TBL] [Abstract][Full Text] [Related]
45. Structure and different conformational states of native AMPA receptor complexes.
Nakagawa T; Cheng Y; Ramm E; Sheng M; Walz T
Nature; 2005 Feb; 433(7025):545-9. PubMed ID: 15690046
[TBL] [Abstract][Full Text] [Related]
46. Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.
Holm MM; Lunn ML; Traynelis SF; Kastrup JS; Egebjerg J
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12053-8. PubMed ID: 16099829
[TBL] [Abstract][Full Text] [Related]
47. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
48. The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
Clausen RP; Naur P; Kristensen AS; Greenwood JR; Strange M; Bräuner-Osborne H; Jensen AA; Nielsen AS; Geneser U; Ringgaard LM; Nielsen B; Pickering DS; Brehm L; Gajhede M; Krogsgaard-Larsen P; Kastrup JS
J Med Chem; 2009 Aug; 52(15):4911-22. PubMed ID: 19588945
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
Armstrong N; Gouaux E
Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
[TBL] [Abstract][Full Text] [Related]
50. Structure of the S1S2 glutamate binding domain of GLuR3.
Ahmed AH; Wang Q; Sondermann H; Oswald RE
Proteins; 2009 May; 75(3):628-37. PubMed ID: 19003990
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
[TBL] [Abstract][Full Text] [Related]
52. On the mechanisms of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate.
Fenwick MK; Oswald RE
J Biol Chem; 2010 Apr; 285(16):12334-43. PubMed ID: 20110361
[TBL] [Abstract][Full Text] [Related]
53. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
[TBL] [Abstract][Full Text] [Related]
54. Mechanism of glutamate receptor desensitization.
Sun Y; Olson R; Horning M; Armstrong N; Mayer M; Gouaux E
Nature; 2002 May; 417(6886):245-53. PubMed ID: 12015593
[TBL] [Abstract][Full Text] [Related]
55. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of Tet-AMPA [tetrazolyl-2-amino-3-(3-hydroxy-5-methyl- 4-isoxazolyl)propionic acid] analogues at ionotropic glutamate receptors GluR1-GluR4. The molecular basis for the functional selectivity profile of 2-Bn-Tet-AMPA.
Jensen AA; Christesen T; Bølcho U; Greenwood JR; Postorino G; Vogensen SB; Johansen TN; Egebjerg J; Bräuner-Osborne H; Clausen RP
J Med Chem; 2007 Aug; 50(17):4177-85. PubMed ID: 17672447
[TBL] [Abstract][Full Text] [Related]
57. Structural dynamics of an ionotropic glutamate receptor.
Kubo M; Ito E
Proteins; 2004 Aug; 56(3):411-9. PubMed ID: 15229875
[TBL] [Abstract][Full Text] [Related]
58. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
[TBL] [Abstract][Full Text] [Related]
59. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
60. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
D'Aoust JP; Tiberi M
Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
